Anthony Scriffignano has over 35 years’ experience in information technologies, Big-4 management consulting, and international business. Scriffignano leverages deep data expertise and global relationships to position Dun & Bradstreet with strategic customers, partners, and governments. A key thought leader in D&B’s worldwide efforts to discover, curate, and synthesize business information in multiple languages, geographies, and contexts, he has also held leadership positions in D&B’s Technology and Operations organizations. Dr. Scriffignano has extensive background in linguistics and advanced computer algorithms, leveraging that background as primary inventor on multiple patents and patents pending for D&B.
Scriffignano regularly presents at various business and academic venues in the U.S., Europe, Latin America, and Asia as a keynote speaker, guest instructor, and forum panelist. Topics have included emerging trends in data and information stewardship relating to the “Big Data” explosion of data available to organizations, multilingual challenges in business identity, and strategies for change leadership in organizational settings.

Scriffignano also confers with key customers on emerging trends in global data science. He was profiled by InformationWeek in a special coverage series “Big Data. Big Decisions” and by BizCloud regarding big data problem formulation and data privacy. He was also published in the May, 2014 edition of CIO review (“The Future Belongs to the Informed”).
Scriffignano has also held senior positions with other multinational organizations. This experience includes extremely large ERP implementations and worldwide organizational change and technology adaptation efforts. He has advised firms in financial services, manufacturing (chemicals and pharmaceuticals) and information technologies. He maintains CPIM certification from APICS, the internationally-recognized Association for Operations Management, in production and inventory management.

Brent A. Young is vice president of Intel China and director of the China Corporate Strategy Office at Intel Corporation. He is responsible for defining and driving Intel’s China strategies including partnerships, business growth, and reputational strategies in China.

Previously, Young was managing director of China Tech Ecosystem (CTE) Sales and China Product Marketing Group. He led Intel’s overall product marketing in China as well as sales, customer, and go-to-market strategies in the CTE. During his tenure as managing director, the CTE sales team received the company’s highest honor, the Intel Achievement Award, for quickly ramping the ecosystem and shaping the nature of the tablet market toward Intel.

Young joined Intel in 2006 as an open source software strategist before holding a number of management positions leading effective product marketing and sales strategies. He also served as technical assistant and chief of staff to Tom Kilroy, executive vice president and general manager of Intel’s Sales and Marketing Group. Prior to joining Intel, he spent 5 years developing core product features and strategic marketing in various software engineering positions at Curl Corporation and ShoppingList.com.

He is a member of Montage Technology Group Limited’s board of directors, an executive-in-residence at Tsinghua University’s X-labs incubator, and a mentor at Chinaccelerator.

Young earned a bachelor’s degree and master’s degree in Computer Science from Cornell University and received an MBA specializing in Strategy, Marketing, and Finance from Northwestern University’s Kellogg School of Management.

Annie Yin is Senior Regulatory Affairs Director for J&J Medical China. She has over 20 years of experience in the health sector, including pharmaceuticals, medical devices and in-vitro diagnostics. Prior to joining J&J Medical China, Annie worked for Eli Lilly, Roche Pharma R&D Center, Sanofi-Aventis, Beckman Coulter and Medtronic. She also brings her experience as a pharmacist at a hospital in China to her work in the private sector. Annie is an active member of several professional societies, including as Chair of the EUCCC HCE Working Group, the Vice-Chair of the RAPS China Advisory Committee and RAPS Global Faculty. She is also the Co-Chair of the AdvaMed IVD Working Group and the Standing Director of the China Society for Drug Regulation.

Bruce Fu is senior director and co-lead of APCO Worldwide's global technology practice based in Beijing. He has a deep knowledge of China’s technical standards, IPR and competition-related issues in the ICT sector. At APCO, Mr. Fu provides clients with ongoing support on market research, operations management, issues monitoring and policy analysis across a variety of sectors.

Prior to joining APCO, Mr. Fu was a business manager at the European Chamber, where he worked closely with the European telecommunications industry by lobbying China’s telecommunications policies and regulations. He partnered with ICT Working Group members such as Nokia, Ericsson, NSN, Sony Ericsson and SAP on telecommunications regulatory policies and TBT/Standards. He also directly engaged Chinese authorities such as MOFCOM, SAIC and NDRC on antitrust issues related to implementing rules of Chinese anti-monopoly law.

Mr. Fu also conducted a comprehensive research project on the Chinese health care market for an international consulting firm based in Antwerp, Belgium.

Mr. Fu obtained master's degrees in European studies and European modern history from the Catholic University of Leuven. He is fluent in English and Chinese and speaks intermediate French.

Dr. Ding Wei is currently employed with Oracle China as Senior Director of Standards Strategy and Policy, where he directs Oracle standardization and policy strategy in China. Prior to this position in Oracle, he was working for Intel (China) Co. Ltd as Standardization Specialist, and previously, acted as the Standards Strategy Manager in Sun Microsystems. He graduated from Dept. of Computer Science and Engineering, Shanghai Jiaotong University.